Elevance Health (ELV) Cash from Investing Activities (2010 - 2026)

Elevance Health (ELV) has 17 years of Cash from Investing Activities data on file, last reported at -$1.6 billion in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$1.6 billion, down 1694.17% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.1 billion (down 12.16% YoY), and the FY2025 annual result was -$1.3 billion, up 73.99% from the prior year.
• Cash from Investing Activities retreated to -$1.6 billion in Q1 2026 per ELV's latest filing, from $464.0 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $464.0 million in Q4 2025 and troughed at -$3.2 billion in Q1 2023.
• A 5-year average of -$1.1 billion and a median of -$1.0 billion in 2023 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities soared 129.92% in 2022, then sank 1694.17% in 2026.
• A 5-year view of Cash from Investing Activities shows it stood at $289.0 million in 2022, then plunged by 456.06% to -$1.0 billion in 2023, then plunged by 59.18% to -$1.6 billion in 2024, then jumped by 128.33% to $464.0 million in 2025, then plunged by 453.88% to -$1.6 billion in 2026.
• Business Quant data shows ELV's Cash from Investing Activities at -$1.6 billion in Q1 2026, $464.0 million in Q4 2025, and -$1.2 billion in Q3 2025.